Clostridium difficile ileitis in a patient, after total colectomy

Aneta Tarasiuk-Rusek1, Kairav J Shah2

  • 1Division of Infectious Diseases and Global Medicine, University of Florida, Gainesville, Florida, USA.

BMJ Case Reports
|February 24, 2016
PubMed

Insights

A post-colectomy patient experienced Clostridium difficile infection (CDI) symptoms including diarrhea and fever. Prompt treatment with vancomycin and flagyl led to symptom resolution and discharge.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Colorectal Surgery

Background:

  • Clostridium difficile infection (CDI) is a significant cause of infectious diarrhea, particularly in post-surgical patients.
  • Total colectomy increases the risk of altered gut microbiota and susceptibility to enteric infections.
  • Early recognition and management of CDI are crucial for patient outcomes.

Observation:

  • A 63-year-old patient, status post total colectomy, presented with watery diarrhea, abdominal cramping, and fever.
  • Abdominal CT revealed diffuse small bowel thickening and mesenteric edema, indicative of infectious enteritis.
  • Clostridium difficile PCR testing confirmed the presence of infection.

Findings:

  • The patient received oral vancomycin and intravenous metronidazole (flagyl).
  • Initial management included bowel rest and nasogastric (NG) tube placement due to ileus.
  • Symptoms resolved within 7 days, leading to successful hospital discharge.

Implications:

  • This case highlights the importance of considering CDI in post-colectomy patients presenting with gastrointestinal symptoms.
  • Appropriate antibiotic therapy and supportive care can effectively manage CDI in this high-risk population.
  • Multidisciplinary collaboration, including surgical consultation, is valuable in complex cases.

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
833
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
855
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
605
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.2K